There are no News articles on ACEL.
We currently have no Breaking News on this stock.
ACEL vs. ETF Alternatives
Tamir Biotechnology, Inc. (formerly Alfacell Corporation) is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges... More
Other News & PR